Andreas P. Kalogeropoulos
Stony Brook University Hospital
ORCID: 0000-0002-1284-429XPilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Tocilizumab versus baricitinib in hospitalized patients with severe COVID-19: an open label, randomized controlled trial”.
Ourania Papaioannou, Panagiota Tsiri, Matthaios Katsaras, Andreas Katsimpris, Andreas P. Kalogeropoulos +14 more
Muthiah Vaduganathan, Ayman Samman-Tahhan, Andreas P. Kalogeropoulos, Vasiliki V. Georgiopoulou, Gregg C. Fonarow +3 more
Gregory D. Lewis, Andreas P. Kalogeropoulos
Christine De Staercke, Ian Everitt, Alice Haouzi, Yi‐An Ko, S G Jennings +6 more
Andreas P. Kalogeropoulos, Victoria Alvarado, Michelle Weisfelner-Bloom, Christopher J. Clarke, Samia Mohammed
Andreas P. Kalogeropoulos, Victoria Alvarado, Michelle Weisfelner-Bloom, Christopher J. Clarke, Samia Mohammed
Rachel Zmora, Yijian Huang, Matthew E. Oster, Courtney McCracken, William T. Mahle +3 more